Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Haemorrhage | 2.2% - 11.9% | x | ||
| Pain | 2.2% - 11.9% | x | ||
| Pregnancy | 0% - 0.7% | x | ||
| Abortion infected | x | |||
| Anaemia | x | |||
| Back pain | x | |||
| Neoplasm malignant | x | |||
| Dysmenorrhoea | x | |||
| Leukorrhea | x | |||
| Cramp muscle | x | |||
| Pelvic infection | x | |||
| Ectopic pregnancy | x | |||
| Urticaria | x | |||
| Vaginal inflammation | x | |||
| Spotting menstrual | x | |||
| Allergic skin reaction | x | |||
| Dyspareunia | x | |||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |